Silence understands the struggles of emotional pain well. A survivor of cancer while pregnant, childhood sexual abuse and domestic abuse, she has known enormous suffering, but she learned to defeat her emotional pain to live free and happy.
Silence has taught clients worldwide on topics such as how to understand that past pain impacts the present, how to liberate yourself from those wounds, and how to connect to your own inner healer to create a life where you not only survive, but also thrive.
Now in her new book, Coming Back to Life: A Roadmap to Healing from Pain to Create the Life You Want, Silence helps readers create an opening to possibility. She provides tools, strategies and support that will allow readers to get to the root of their pain patterns while also receiving hope, encouragement and access to the light at the end of the dark tunnel they may find themselves in.
“What the world desperately needs now more than ever before is a way to navigate trauma and difficult emotions,” said Silence. "How you feel is 100 percent based on how healed your past is. There really is life on the other side of whatever darkness people are facing, and this book offers hope, healing, and a roadmap that is guaranteed to empower and encourage readers to take their lives back from an emotionally clear, neutral and grounded space. You’ll never have to feel powerless again, and that is a promise,” Silence added.
Readers will learn how to:
- Emotionally heal and process through anxiety, depression and past trauma, and re-commit to living a fulfilling life.
- Break free from generational pain patterns to become the most authentic and happy versions of themselves.
- Be the source of their own encouragement, take control over their lives and never feel powerless again.
“Coming Back to Life is the book that the world needs in this moment. It will illuminate what has been invisibly holding you back and give you a clear path to feeling good and getting what you want,” said Stephen Lovegrove, America’s Life Coach.
About the Author
Rebeccah Silence is a global advocate and leading coach in emotional healing and relationships. As a survivor of childhood trauma and abuse, and being diagnosed with Stage 3 cancer while she was pregnant, she has helped countless individuals, couples and families process even the most intense traumatic experiences — and heal!
An accomplished TV and radio personality with over two decades of experience speaking to millions about doing the inner work, Silence is a groundbreaking voice in the space of healing and self-development. Her life’s mission is about supporting people in moving through their healing so they can allow themselves to truly thrive.
Silence is the author of Coming Back to Life, host of the Healing IS Possible Experience and the Tougher Together Breakthrough podcast, and the creator of the on-demand The Emotional Survival Kitcourse. Through her coaching, seminars, books and online courses, Silence teaches audiences how to become their own healers, how to love and trust themselves, and how to be their best for others and the world. She currently lives in Boulder, Colorado, with her husband, two daughters and two dogs. Visit her website: rebeccahsilence.com.
Coming Back to Life: A Roadmap to Healing from Pain to Create the Life You Want Publisher: HCI Books Release Date: October 11, 2022 ISBN-10: 0757324460 ISBN-13: 9780757324468 Trade Paperback, 256 pages Available for pre-order on Amazon.com
24h Tremblant Announces Major Partnership with Sun Life
MONT-TREMBLANT, QC, Sept. 15, 2022 /CNW/ - The 24h Tremblant announced today that it has signed a three-year agreement with Sun Life, making the insurance giant the event's exclusive presenting sponsor.
This important partnership will boost the event's momentum over the next few years. Coming on the heels of pandemic challenges, this support spells welcome news for the future of the 24h Tremblant. Sun Life's financial contribution allows the organization and participants to focus entirely on raising funds for children's causes. And we are witnessing the enthusiasm: more than 320 teams have already signed up. At this rate, our goal of 500 teams in 2022 is well within reach!
"Sun Life is pleased to be associated with this major winter sports challenge, a favourite with sports enthusiasts for the past 21 years," said Robert Dumas, president and CEO of Sun Life Quebec. "At Sun Life, we're building a healthy future for our clients, employees, and communities. We share the values of wellness and surpassing oneself that are promoted by 24h Tremblant. We are looking forward to being at the starting line on December 10."
"We are very pleased to have Sun Life join us as a major partner for our 22nd edition on the mountain," said Simon St-Arnaud, executive producer of the 24h. "This alliance is much more than financial support. Sun Life will participate actively in the event with its own teams, which are doing their own donation drives, and improving the experience in many ways for participants. That is the definition of a real partnership."
The next edition of the 24h Tremblant takes place this coming December 9 to 11. Skiers, runners and walkers are invited to join the event and experience a weekend of sports and fun in support of children's causes. A notable new feature this year is that alpine touring has been added to the disciplines.
Sun Life is committed to building sustainable, healthier communities for life. Community wellness is an important part of its sustainability commitment. By actively supporting the communities in which Sun Life lives and works, the organization can help build a positive environment for Clients, employees, advisors, and shareholders. Its philanthropic support focuses on health, with an emphasis on diabetes awareness, prevention, and care initiatives. Mental health is also a key priority, with support for programs and organizations with an emphasis on building resilience and coping skills.
Sun Life also partners with sports properties in key markets to further our commitment to healthy and active living. Its employees and advisors take great pride in volunteering more than 16,000 hours each year and contribute to making life brighter for individuals and families across Canada.
Since its inception in 2001, the 24h Tremblant – the largest charity event in the North American ski industry – has raised $43,011,126 for various organizations. On average, 78% of the donations raised by the event are remitted each year. Fondation Charles-Bruneau, the CHEO Foundation and Fondation Tremblant are the primary beneficiaries of the generosity of thousands of donors. The funds raised are essential to providing children with a better quality of life and to helping fund innovative medical projects in pediatric hematology-oncology, because hope comes through research.
Each year, the event attracts over 30,000 people, 4,000 participants and 425 teams, who ski, run and walk for 24 hours thanks to the commitment of 350 volunteers.
Amprion Exhibits at MDS International Congress of Parkinson’s Disease and Movement Disorders in Madrid and Presents Scientific Insights On SYNTap® Test at the International Conference Prion2022
San Francisco
Amprion, a leader in diagnostics for neurodegenerative diseases, invites researchers and practitioners attending MDS to visit Amprion at booth #212. We look forward to discussing how the SYNTap® Biomarker Test addresses the unmet medical need for a validated clinical test to diagnose Parkinson’s disease (PD) and differentiate PD from atypical Parkinson’s at early stages. Accurate and early diagnosis helps accelerate personalized treatment and therapeutic innovations.
The urgent medical need for accurate, early diagnosis of neurodegenerative diseases is growing as the global population ages. For every thousand individuals, 1 to 2 persons are impacted by Parkinson's. PD’sprevalence increases with age, affecting 1% of the population aged 60 and above. Globally, about 10 million people may be afflicted by PD.
“The SYNTap Test fills the void for a highly sensitive and specific clinical diagnostics tool,” said Amprion Chief Scientific Officer Claudio Soto, Ph.D., who will speak at Prion2022, September 13-16 in Göttingen, Germany. According to Russ Lebovitz, MD/Ph.D, Amprion CEO, “A confident diagnosis helps optimize personalized treatment and disease management strategies for people living with Parkinson’s and Movement Disorders.” Dr. Lebovitz will attend MDS, International Congress of Parkinson’s Disease and Movement Disorders in Madrid, September 15-18.
Amprion will host a Meet the Expert session in which attendees can discuss scientific insights on how the SYNTap Test performs in a clinical setting.
MEET THE EXPERT – Friday, Sept. 15TH - 10 am to 12 pm - Booth #212
Neurologist Brit Mollenhauer, MD, specializes in Parkinson’s Disease and Movement Disorders and is head of translational research at the Paracelsus-Elena Klinik (PEKK) in Germany. She has developed a study center for clinical trials and translational research and works closely with the Michael J. Fox Foundation for Parkinson’s Research.
"The SAA developed by Amprion offers a highly accurate detection of misfolded Synuclein in cerebrospinal fluid (CSF), which can be diagnostic for patients suspected of having Parkinson's, Lewy Body Dementia, and Multiple System Atrophy, all of which are Synuclein Aggregation Disorders.”
Dr. Mollenhauer will discuss the value of Amprion’s SYNTap Test in the early identification of Synucleinopathy based on her studies: “We have shown that in one of our patient cohorts with REM Sleep Behavior Disorder (RBD), a prodromal condition for Synuclein Aggregation Disorders, the SYNTap Test can detect misfolded Synuclein at least a decade prior to the time a clinical diagnosis of Synuclein Aggregation Disorders can be made.”
We look forward to connecting with you at MDS booth #212.
A leader in Prion Detection Science™, Amprion innovates biomarker testing for brain diseases. Our SYNTap® Biomarker Test aids in diagnosing Parkinson’s Disease, Lewy Body Dementia, and Lewy Body Variant of Alzheimer’s. Amprion has been granted FDA Breakthrough Device Designation for detecting misfolded Synuclein in CSF. We strive to accelerate personalized medicine for neurodegenerative diseases through molecular testing.
Users of Pioneering Stress-Relief System Reach Milestone, Changing Their Mental State without Drugs
NuCalm’s Popularity Increases Dramatically Following Consumer Product Launch
WILMINGTON, DELAWARE – USA (Issued September 2022) – Since last year’s introduction of the NuCalm consumer stress-relief product and subscription program, thousands of users around the world have been able to control the triggers that result in fear, stress, anxiety, depression, worry and sleeplessness. The need to find effective solutions to take better care of ourselves during this high stress COVID-19 era is self-evident as NuCalm users surpassed over 100 million minutes, enabling users to “Own the day.”
Jim Poole, CEO/President of Wilmington, Delaware-based Solace Lifesciences, maker of NuCalm (www.NuCalm.com), says, “After 32 years and millions of dollars of research, we’re proving every day how effective our patented, clinically-proven neuroacoustic software is. We are getting closer to achieving our mission to change the world with the successful transition from a medical device to a consumer product. Now, for the first time in history, people can change their mental state on demand without drugs or side effects. All you do is listen to our patented neuroacoustic software to dial up or dial down your brain wave frequencies to create whatever outcome you want; from the deepest levels of sleep to recovery and restoration to the highest levels of intensity and mental focus.”
NuCalm has been successfully used in over two million surgical procedures and by individuals suffering from PTSD, addiction, patients undergoing cancer treatment, first responders, pilots, and stressed-out executives. It’s used by FBI agents, across the Department of Defense, and by many of the world’s best athletes across 54 professional sports teams.
Among NuCalm devotees are ultramarathoner Robbie Belanger who used it nightly to help him complete the daunting ‘Colorado Crush’ mountain challenge and the Tesla challenge where he outlasted a Tesla’s battery; and author/motivational speaker Tony Robbins who wrote about it in his latest book, “Life Force.”
NuCalm has been featured on NBC’s Today Show, MSNBC, USA TODAY,The Wall Street Journal, Forbes, and won prestigious awards at the Consumer Electronics Show. The company hosted a NuCalm Recovery Lounge at Enshrinement Week at thePro Football League Hall of Fame in Canton, Ohio, at Super Bowl week in Los Angeles, and at the US Open Tennis Championships in New York. The company has also donated hundreds of thousands of dollars of NuCalm systems to veterans suffering with PTSD across the U. S.
ViVitro Labs Introduces World's first "Set it and forget it" Heart Valve Durability Tester
New Heart Valve Durability tester with Automatic Dual Control technology debuts at the 34th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation.
"Introducing a New Generation of Durability Testers"
VICTORIA, BC, Sept. 16, 2022 /CNW/ - ViVitro Labs, the industry-leading provider of cardiovascular device test equipment and related consulting services, announces the launch of a revolutionary, self-regulating heart valve durability tester, the ViVitro Labs Heart Valve Durability Tester with ADC™ technology (https://vivitrolabs.com/product/adc-heart-valve-durability-tester/ ) at TCT 2022 in booth 542 on September 17-19, 2022, at the Boston Convention and Exhibition Center (BCEC)".
Heart Valve Durability Testers measure the longevity and performance of artificial heart valve prostheses in accelerated conditions to ensure devices are safe before being used in patients.
A multidisciplinary team of mechanical, electronic, and software engineers spent more than 3 years in R&D developing the device, drawing upon extensive experience in the field of cardiovascular device testing. The team incorporated feedback from industry leading cardiovascular device companies, start-ups, universities, testing labs, and consultants throughout the process.
The ViVitro Labs Heart Valve Durability Tester received enthusiastic praise during preliminary product evaluation demonstrations over the past 10 months from companies including Medtronic, Edwards, Abbott, and Boston Scientific.
Preliminary product evaluation feedback on two key features:
Independent standalone architecture with true independent test modules
"The truly independent nature of each station means downtime could be much less."
"I like dealing with the modularity. Distinct units that are separate and don't communicate with each other. You're not loading up the whole thing and can have 1 or all 6 going."
"Impressed by the standalone architecture. It's great for early-stage R&D when samples are scarce."
Chamber size and visibility
"I appreciate the visibility of the valve, the side views, and the visual from top and bottom."
"You can see all 6 chambers at the same time. In one look, you know if anything is wrong."
"I like the idea of having this chamber we could modify or put different things into."
Karim Mouneimne, President of ViVitro Labs Inc. and General Manager of Vivitro Labs SASU, explains a key benefit of the ADC™ technology, "This technology helps avoid over pressurizing and over opening valve samples during testing thus improving reliability and reducing costly false negative results.
I am thrilled to present our new Heart Valve Durability tester with Automatic Dual Control technology at TCT 2022 in booth 542 on September 17-19, 2022, at the Boston Convention and Exhibition Center (BCEC)."
About ViVitro Labs
ViVitro Labs Inc., Canada, offers industry-leading cardiovascular test equipment and related laboratory testing and consulting services. Hundreds of organizations in over 39 countries for 35 years have trusted ViVitro expertise, accuracy, and quality for their heart valve, LVAD, TAH, stent, and graft testing. ViVitro Laboratory Services holds ISO/IEC 17025 accreditation based on ISO 5840. ViVitro Labs products are manufactured by StarFish Medical in Victoria, Canada. (see our ISO 17925 scope of accreditation for Marseille, France and Victoria, Canada).
Former NFL Player’s Book Says Inclusive Competitiveness is Key to Future U.S. Economic Prosperity
Arlington, VA, September 16, 2022 — Some may only know Johnathan Holifield as a former Cincinnati Bengals running back, but since his stint in the NFL, he’s been anything but idle. Now senior vice president for new economies at Bitwise Industries, Holifield has gained important insight into America’s economic engine and why, he says, the country can’t win without strengthening at once inclusion and competitiveness.
Holifield’s vision of the future economy is achieving more with the goal of getting “all hands on deck.” According to his model, this will happen only by including disconnected Americans, such as women, African Americans, Latinos and rural populations, in America’s economic competitiveness priorities and no longer relegating their aspirations to less productive areas of the economy.
The book “offers a clear critique of how we got to such low productivity of underserved humans in the Innovation Economy,” Holifield said. “… and an even clearer, implementable path to achieving genuine economic inclusion and competitiveness.”
The Future Economy and Inclusive Competitiveness is an important read for anyone who is passionate about community transformation, generational wealth creation and U.S. competitiveness, and interested in a proven framework to make them happen.
Holifield’s unique background effectively carrying out inclusive competitiveness in the government and private sectors and more, has given him equally unique and actionable ideas. In regard to his early mover position, he says he “may be the first person to explicitly link improved U.S. global competitiveness to diversity, equity and inclusion.”
About the Author
Johnathan Holifield has worn many hats and carried many titles during his career. Dubbed the Architect of Inclusive Competitiveness, Holifield is currently the senior vice president for new economies at Bitwise Industries. The Future Economy and Inclusive Competitiveness: How Demographic Trends and Innovation Can Create Economic Prosperity for All Americans is his first book.
Holifield has over 20 years of diverse experience, effectively translating concepts into presidential policy, federal law, and organizational and local development strategies. He served as executive director of the White House initiative on Historically Black Colleges and Universities (HBCU). His other previous roles included vice president of inclusive competitiveness at NorTech, founding executive director of CindyTech and vice president of new economy enterprise at the Cincinnati USA Chamber.
Soaring Demand for Christian Hip-Hop Propels Rise of Holy Culture Radio
Wilmington, DE, September 16, 2022 — In April, Holy Culture Radio (HCR), a staple in the Christian hip-hop community, expanded to a full-time “edutainment” channel on SiriusXM Radio,broadening its reach into its faith-based rap audience.
“There has always been a question of whether there is a market for Christian hip-hop music,” said James Rosseau, founder of the nonprofit organization that operates HCR. “I believe our 5 million subscribers have shown that the genre has broad viability given the above average listener engagement we’ve seen across our 14 shows and music mixes as we play a wide diversity of Christian hip-hop artists.”
HCR’s programming features faith-based rap and rhythmic music from some of the biggest names and upcoming artists, a variety of DJ mixes, and empowering conversations intended to educate and inspire its audience.
“I am ecstatic at how God has moved in just over four months, allowing us to leverage our extended platform to share the voices of more than 300 artists with millions. Further, I could not be more proud of the HCR Squad — from our hosts and DJs, to the internal team, that is making it all happen!” Rosseau said.
With a focus on the themes of Faith, Arts, Vocation and Education (FAVE), Rosseau says that HCR provides a unifying blend of three factors important to its audience: connection to popular culture, connection to their faith and success in their careers.
“HCR acts as a megaphone/amplifier of awareness, a portal for tools, and the creation of a community and movement that helps people find their superpowers and learn how to activate them,” Rosseau said, adding that while the platform serves all, they are very focused on young African Americans.
Holy Culture Radio is owned and operated by The Corelink Solution, a nonprofit founded by Rosseau that delivers curriculums “to help people develop their passion and purpose, create an informed plan, use provided tools to help them succeed, and establish accountability and ownership.”
The Holy Culture brand aims to promote Christian values and lifestyle through media.
Holy Culture Radio can be heard on SiriusXM Channel 154.
Learn more at www.holyculture.net, or follow Holy Culture on Twitter (holyculture), Instagram (holyculture), YouTube (holyculture) Facebook (holyculturenet) and TikTok (@holyculture.net).
And save 10% on any sale going on now until the end of the month.
They have tons of options for whatever wall you are decorating!
I have also teamed up with WeCOOK again this month!
Use Code:
Trainitright70
To save on this amazing meal delivery service!
Also
I am accepting clients now:
Let me help you! Theres no better time than now to start!
Need help with training, nutrition and supplementation? I have online coaching slots available.
I can help! I now have client spots open....
SERIOUS INQUIRES ONLY.
I have helped hundreds of men and women achieve their goals not just for stage but through transformation/lifestyle coaching.
For anyone interested in coaching - I have limited spots available for prep, off-season and transformation left. So if you are serious about your goals.Contact me NOW or Sign Up HEREI also do ONLINE POSING for: BIKINI FIGURE WELLNESS MENS PHYSIQUEContact me NOW
Not interested in coaching but still want to support me and my sport....click HERE Thanks so much!
CloudMD’s TAiCBT Results in Significant Improvement for PTSD Across Symptom Severity Levels, Trauma Types and Demographics
Recent research study demonstrates that the majority of clients experience reliable improvement in symptoms after just two months of treatment
VANCOUVER, British Columbia, Sept. 15, 2022 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a healthcare technology and innovative health services company transforming the delivery of care, today released a research study that demonstrates the positive outcome results from using its therapist-led internet based cognitive behavioural therapy (TAiCBT) for individuals suffering from posttraumatic stress disorder (PTSD) across symptom severity levels, trauma types and demographics.
PTSD is a debilitating condition often exacerbated by long wait times and lack of access to effective treatment. The first line psychological treatments for PTSD are rooted in principles of cognitive behavioural therapy (CBT). Digital delivery of these therapies represents an opportunity to improve access to evidence-based treatment that can reduce symptoms of posttraumatic stress.
CloudMD recently completed its study to determine the effectiveness of its TAiCBT for posttraumatic stress and examine how pre-treatment client characteristics are related to key outcomes. The sample consisted of individuals with histories of traumas ranging from experiencing sexual assault to observing work-related suffering; this enabled researchers to also explore the relationship between these diverse histories and treatment outcomes.
Highlights of Results:
Between January 2020 and June 2022, 4,236 people consented to treatment for symptoms of posttraumatic stress, and 3,689 of those completed at least one post assessment outcome measure.
Clients reported significant symptoms: 96% reported symptoms that exceeded the threshold for being a clinical case and 68% also reported serious symptoms of depression and anxiety, as well as impaired functioning in day-to-day activities.
Clients reported a range of trauma histories: 68% reported ‘other unwanted or uncomfortable sexual experience’, 59% reported physical assault, 56% reported sexual assault, 36% reported a transportation accident, and 54% reported ‘other very stressful event’.
When broken down by gender, unwanted sexual experiences and assaults (both physical and sexual) were the most reported experiences for women. For men, the most reported traumatic experiences were physical assaults, other stressful experiences or a transportation accident.
On average, clients started treatment within 7 calendar days of submitting an assessment, with 71% of treatment content completed outside of standard work hours.
The CloudMD treatment had a large and statistically significant effect on clients’ posttraumatic stress symptoms and a moderate effect on symptoms of depression, anxiety and functional impairment.
Most clients achieved significant symptom reduction with the percent increasing as clients complete more treatment content: 61% of clients who engage with the trauma-focused content experience a reliable improvement in their symptoms, and 77% who engage with the consolidation content experience reliable improvement with an average reduction of 23 points on the PTSD Checklist for DSM-5.
Treatment was effective for the full range of symptom scores. Clients with higher baseline trauma symptom scores were more likely to achieve reliable symptom improvement than those with lower scores.
All client types were equally likely to achieve reliable symptom improvement: demographic characteristics and trauma type were not predictive of engagement with treatment or of symptom change.
Most studies of TAiCBT for PTSD focus on specific subsets of the population, such as groups that are assumed to have employment-related exposure to trauma, including members of the military (or veterans), first-line responders (EMTs, ER physicians), or law enforcement (Straud et al 2019; Stephanopoulou et al 2020). Given that interpersonal trauma – such as physical and sexual assault – accounts for a large proportion of PTSD cases (Bedoya et al., 2020), research on the effectiveness of TAiCBT for posttraumatic stress would benefit from expanding the field of study to include broader populations, which is exactly what this study does.
In addition to evaluating the efficacy of CloudMD’s posttraumatic stress treatment protocol to determine whether accessible, low-intensity treatment options would be effective for posttraumatic stress across the full spectrum of symptom severity, CloudMD’s researchers also explored the effect of sample-specific factors on treatment outcomes. Researchers examined whether pre-treatment client characteristics such as gender, age, and trauma type, predicted differential response to treatment.
“This study solidifies the importance of offering therapy for posttraumatic stress alongside depression and anxiety therapy to complement care and provide truly effective treatment for anyone needing trauma support, not only the first-responder community,”shared Karen Adams, President and CEO, CloudMD.“Our data allows for better understanding of the conditions and the impact of targeted treatments. This helps employers make informed choices when they evaluate workplace mental health investments by equipping them with critical insights,”she continued.
The study demonstrates the basic effectiveness of CloudMD’s TAiCBT program for posttraumatic stress in a real-world heterogenous sample of help-seeking individuals. More than half of clients experienced significant reduction in trauma symptoms; 38% of clients experienced reductions in depression and anxiety; and 28% of clients reported improvements in day-to-day functioning. The program led to reductions in symptoms for clients across the range of symptom severity. While the longer a client spent engaged in treatment, the greater their likelihood of achieving symptom improvement, many clients who did not complete all phases of therapy experienced reliable symptom improvement. These results indicate that offering low-intensity treatment for posttraumatic stress is a viable and frequently sufficient entry point to care.
“Our TAiCBT program enables us to break down barriers to evidence-based care that many individuals experience, such as lack of accessible or specific treatments. We’ve been able to successfully treat clients with varying severity of post traumatic symptoms,”said Dr. Leorra Newman, Clinical Content Lead, CloudMD. “This study highlights that targeting post traumatic symptoms directly can lead to associated improvements in levels of anxiety, depression, and functioning - making a true difference in our clients’ lives,” Newman added.
Accessing evidence-based mental health treatment in a timely manner is challenging, taking 25 business days in Canada to access typical community-based services, with wait times for specific conditions like PTSD reaching approximately two years. This lack of accessibility is a significant problem for individuals, their families, employers and many other parts of society. CloudMD provides timely access to TAiCBT within days of a completed assessment, accelerating access, providing support outside regular office hours, and alleviating demand on traditional pathways.
Furthermore, the effectiveness of CloudMD’s programs showcases the value of selecting evidence-based mental health treatment for HR leaders investing in the well-being of their staff. As shown in this study, CloudMD has a proven, highly effective treatment for people with diverse histories of trauma and demographic characteristics.
CloudMD will be hosting a webinar to discuss the research on September 28th, 2022 at 9am PT/12pm ET as part of its Better Outcomes Initiative. Individuals can register for it here: Better Outcomes Webinar Registration.
About CloudMD Software & Services
CloudMD is transforming the delivery of healthcare using technology and by providing a patient-centric approach, with an emphasis on continuity of care. By leveraging healthcare technology, the Company is building one, connected platform that addresses all points of a patient’s healthcare journey and provides better access to care and improved outcomes. Through CloudMD’s proprietary technology, the Company delivers quality healthcare through a holistic offering including hybrid primary care clinics, specialist care, telemedicine, mental health support, healthcare navigation, educational resources, and artificial intelligence (AI). CloudMD’s business is separated into three main divisions: Clinics and Pharmacies, Digital Solution and Enterprise Health Solutions, the Company’s fastest growing division. CloudMD’s Enterprise Health Solutions Division has built a leading employer healthcare solutions, including its Comprehensive Integrated Health Services Platform, which offers one comprehensive, digitally connected platform for educational institutions, corporations, insurers, and advisors to better manage the health and wellness of their students, employees, and customers.
CloudMD currently services a direct ecosystem of over 5,700 clinicians including, 1,800+ mental health practitioners, 1,600+ allied health professionals, 1,400+ doctors and nurses and covers 12 million individual lives across North America. For more information visit: https://investors.cloudmd.ca.
ON BEHALF OF THE BOARD OF DIRECTORS
“Karen Adams” Chief Executive Officer
Ultimate Anti-aging Rêvolution - Firming Redensifying Mask Announced as a top-performing Face Mask in 2022 Clean Beauty Awards
MONTREAL, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Zorah biocosmétiques’ Ultimate Anti-aging Rêvolution – Firming Redensifying Mask has been named winner of the Face Mask Category in CertClean’s 7th annual Clean Beauty Awards. The esteemed Clean Beauty Awards were created to acknowledge and reward superior beauty and personal care products formulated without the use of harmful chemicals by trailblazers in the clean beauty market.
More than 450 best-selling, clean beauty products were nominated for this year’s awards and were judged by an international panel of 146 beauty specialists. Finalists/Winners/Top3 were chosen in each of the 24 product categories.
“I am so grateful that our Rêvolution anti-aging mask has won first place in the face mask category. Our team worked really hard to develop this amazing product!
We were able to combine the great virtues of silver powder, organic argan oil and other natural ingredients to come up with this anti-aging, hydrating and soothing face mask.”Mélissa Harvey – Zorah Biocosmétiques Founder & CEO.
The RÊVolution ultimate anti-aging mask with pure silver firms and tightens the skin, providing intense hydration for mature skin. Used for thousands of years, pure silver has healing, purifying, soothing and anti-aging properties. This face mask was designed to nourish and help restore skin’s radiance, suppleness and vivacity.
RÊVolution Ultimate anti-aging cream – Finalist in the face cream category One of Zorah's bestsellers! This hydrating, firming and plumping treatment was designed for sensitive mature skin. A large quantity of pure silver, which has been used for thousands of years in alternative medicine, is in this treatment to provide healing, purifying, soothing and anti-aging properties.
About Zorah Biocosmétiques
Founded 15 years ago following a humanitarian trip in Morrocco, Zorah is a high-performance, argan oil based, 100% natural skin care brand.
Zorah is now a well-established company in Quebec and Canada, with more than 1,000 points of sale (Jean Coutu, Brunet, Rachel Berry and other independent retailers) and recently launched on the Shoppers Drug Mart online store.
For more information visit zorah.ca and follow Zorah on Facebook and Instagram @zorahbiocosmetiques.
About Clean Beauty Awards
Established in 2015, the Clean Beauty Awards is the leading awards program honouring excellence in clean beauty and personal care products. The 7th annual Clean Beauty Awards received 455 entries from Canada, the US, Australia and throughout Europe.
